DAVID SCHNALL: Open Payments
NPI 1164198479 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 68 payments from 15 companies in 2025. Trend: 2023 $705 · 2024 $758 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $283 |
| Janssen Biotech, Inc. | 9 | $269 |
| Sumitomo Pharma America, Inc. | 9 | $240 |
| Astellas Pharma US Inc | 9 | $195 |
| TOLMAR, INC. | 8 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| ABBVIE INC. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $49 |
| IMMUNITYBIO, INC. | 2 | $43 |
Products named: ERLEADA, Nubeqa, Xtandi, GEMTESA, ELIGARD, LYNPARZA, BOTOX, PLUVICTO.
Industry payments across PA — which companies pay providers there.
